Cardiovascular Risk Factor Analysis

This cluster focuses on identifying and analyzing various modifiable and non-modifiable risk factors that contribute to cardiovascular diseases. It encompasses studies that evaluate the effects of these factors on heart health across diverse populations and settings.

myocardial infarction
risk factors
cholesterol levels
coronary heart disease
epidemiology
population studies
modifiable risks
health outcomes

89,031 papers

Parent topic: Cardiovascular Health Analytics

AI-assisted content · The overview, paper groupings, and influence analysis on this page are AI-generated. They are intended as a starting point for exploring the field and may contain inaccuracies. Report an error

Papers Over Time

1930194019501960197019801990200020102020

Top Papers

Effect Of Potentially Modifiable Risk Factors Associated With Myocardial Infarction In 52 Countries (The INTERHEART Study): Case-Control Study.

2004 · 8,883 citations

Prediction Of Coronary Heart Disease Using Risk Factor Categories

1998 · 8,051 citations

Randomised Trial Of Cholesterol Lowering In 4444 Patients With Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S)

1994 · 7,993 citations

Primary Prevention Of Cardiovascular Disease

2002 · 7,486 citations

The Effect Of Pravastatin On Coronary Events After Myocardial Infarction In Patients With Average Cholesterol Levels

1996 · 7,406 citations

MRC/BHF Heart Protection Study Of Cholesterol Lowering With Simvastatin In 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial.

2002 · 6,925 citations

Global Burden Of Cardiovascular Diseases And Risk Factors, 1990–2019

2020 · 6,605 citations

Heart Disease And Stroke Statistics—2015 Update

2015 · 6,190 citations

Randomized Trial Of Estrogen Plus Progestin For Secondary Prevention Of Coronary Heart Disease In Postmenopausal Women

1998 · 5,924 citations

General Cardiovascular Risk Profile For Use In Primary Care

2008 · 5,919 citations

Markers Of Inflammation And Cardiovascular Disease

2003 · 5,517 citations

2016 European Guidelines On Cardiovascular Disease Prevention In Clinical Practice

2016 · 5,449 citations

Major Outcomes In High-Risk Hypertensive Patients Randomized To Angiotensin-Converting Enzyme Inhibitor Or Calcium Channel Blocker Vs Diuretic: The Antihypertensive And Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT)

2002 · 5,302 citations

Particulate Matter Air Pollution And Cardiovascular Disease

2010 · 5,245 citations

C-Reactive Protein And Other Markers Of Inflammation In The Prediction Of Cardiovascular Disease In Women

2000 · 5,236 citations

Inflammation, Aspirin, And The Risk Of Cardiovascular Disease In Apparently Healthy Men

1997 · 5,093 citations

Primary Prevention Of Acute Coronary Events With Lovastatin In Men And Women With Average Cholesterol Levels

1998 · 5,089 citations

Targeting LDL Cholesterol: Early Treatment Is Key To Population Health

2020 · 4,642 citations

Efficacy And Safety Of More Intensive Lowering Of LDL Cholesterol: A Meta-Analysis Of Data From 170,000 Participants In 26 Randomised Trials.

2010 · 4,414 citations

Helsinki Heart Study: Primary-Prevention Trial With Gemfibrozil In Middle-Aged Men With Dyslipidemia

1987 · 4,270 citations